Moreover, pharmacological inhibition of cNK cell infiltration by blocking CCR5 could attenuate liver damage and prolong the survival time of mice, which provides a therapeutic approach to alleviate liver impairment during virus-induced liver injury. Here, CCR5 is linked to injury.